Christopher Moxham

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Peter Thomson, as attorney-in-fact for Christopher Moxham
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Moxham:

Company Role Class Num Shares Value Price $ Report Date Ownership
Fulcrum Therapeutics, Inc. Chief Scientific Officer Common Stock 31,071 $102,845 $3.31 10 Aug 2021 Direct
Fulcrum Therapeutics, Inc. Chief Scientific Officer Stock Option (right to buy) 72,501 10 Aug 2021 Direct
Fulcrum Therapeutics, Inc. Chief Scientific Officer Common Stockm 0 $18.00 10 Aug 2021 Direct

Insider Reports Filed by Christopher Moxham

Symbol Company Period Transactions Value $ Form Type Role Filing Time
FULC Fulcrum Therapeutics, Inc. 10 Aug 2021 6 -$505,422 4 Chief Scientific Officer 12 Aug 2021, 16:20